| 000 | 01793 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515182050.0 | ||
| 264 | 0 | _c20100108 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1878-1780 | ||
| 024 | 7 |
_a10.1016/j.diabet.2009.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVandemeulebroucke, E | |
| 245 | 0 | 0 |
_aInsulin treatment in IA-2A-positive relatives of type 1 diabetic patients. _h[electronic resource] |
| 260 |
_bDiabetes & metabolism _cSep 2009 |
||
| 300 |
_a319-27 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aBelgium |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlucose Intolerance _xprevention & control |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xdiagnosis |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 |
_aProinsulin _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGorus, F K | |
| 700 | 1 | _aDecochez, K | |
| 700 | 1 | _aWeets, I | |
| 700 | 1 | _aKeymeulen, B | |
| 700 | 1 | _aDe Block, C | |
| 700 | 1 | _aTits, J | |
| 700 | 1 | _aPipeleers, D G | |
| 700 | 1 | _aMathieu, C | |
| 773 | 0 |
_tDiabetes & metabolism _gvol. 35 _gno. 4 _gp. 319-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diabet.2009.02.005 _zAvailable from publisher's website |
| 999 |
_c19054805 _d19054805 |
||